Journal of Tuberculosis Research

Vol.5 No.3(2017), Paper ID 78191, 6 pages

DOI:10.4236/jtr.2017.53017

 

Diagnosing Drug-Resistant Tuberculosis with the Xpert®MTB/RIF. The Risk for Rifampin Susceptible Cases

 

Brenda Zaragoza, Rafael Laniado-Laborín

 

Clínica y Laboratorio de Tuberculosis, Hospital General de Tijuana, Tijuana, Mexico
Facultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán, Mexico
Facultad de Medicina y Psicología, Universidad Autónoma de Baja California, Mexico
Regional Green Light Committee for the Americas, World Health Organization, Geneva, Switzerland

 

Copyright © 2017 Brenda Zaragoza, Rafael Laniado-Laborín et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Zaragoza, B. and Laniado-Laborín, R. (2017) Diagnosing Drug-Resistant Tuberculosis with the Xpert®MTB/RIF. The Risk for Rifampin Susceptible Cases. Journal of Tuberculosis Research, 5, 155-160. doi: 10.4236/jtr.2017.53017.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.